Online citations, reference lists, and bibliographies.

Raf-1 Activation In Gastrointestinal Carcinoid Cells Decreases Tumor Cell Adhesion.

D. Y. Greenblatt, M. Kunnimalaiyaan, H. Chen
Published 2007 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Gastrointestinal carcinoid tumors are highly metastatic. Activation of the Raf-1 signaling pathway in carcinoid cells results in morphologic changes. These Raf-1-induced structural changes may affect cellular adhesion, thereby altering metastatic potential. METHODS An estrogen-inducible Raf-1 cell line (BON-raf) was used to study the effects of Raf-1 on cellular adhesion. Cell adhesion was measured before and after Raf-1 induction. Western blot analysis was used to confirm Raf-1 activation and measure levels of an essential adhesion regulator, beta-catenin. RESULTS Estrogen treatment of BON-raf cells resulted in Raf-1 activation and a marked decrease (68%) in cell adhesion. In the absence of Raf-1 induction, carcinoid cells expressed high levels of beta-catenin. Raf-1 activation led to decreased expression of beta-catenin. CONCLUSIONS Raf-1 induction in carcinoid cells results in a significant decrease in adhesion. Furthermore, the important adhesion regulator, beta-catenin, is decreased in activated BON-raf cells. These Raf-1-related changes in adhesion may alter the metastatic phenotype of carcinoid cells.
This paper references
10.1089/THY.2005.15.511
Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1.
H. Chen (2005)
10.1007/s00268-003-7019-3
Gastrointestinal Carcinoid Tumors: Factors that Predict Outcome
J. J. Gompel (2003)
10.1067/MSY.2002.128877
Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation.
R. Sippel (2002)
10.1097/00001813-200602000-00004
The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
M. Kunnimalaiyaan (2006)
10.1016/J.JSS.2006.02.002
ZM336372, a Raf-1 activator, inhibits growth of pheochromocytoma cells.
A. Kappes (2006)
10.1101/GAD.14.15.1837
Wnt signaling and cancer.
P. Polakis (2000)
10.1152/AJPGI.00146.2005
Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells.
M. Kunnimalaiyaan (2005)
10.1016/J.SURG.2005.05.027
Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells.
M. Kunnimalaiyaan (2005)
10.1038/382638A0
Functional interaction of β-catenin with the transcription factor LEF-1
J. Behrens (1996)
10.1038/32433
A causal role for E-cadherin in the transition from adenoma to carcinoma
A. Perl (1998)
10.1016/S0092-8674(00)00122-7
Linking Colorectal Cancer to Wnt Signaling
M. Bienz (2000)
10.1083/jcb.108.6.2435
Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion
J. Behrens (1989)
10.1097/01.cco.0000198018.53606.62
Treatment of advanced carcinoid tumors
A. Lal (2006)
10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D
Mutations of the human E‐cadherin (CDH1) gene
G. Berx (1998)
10.1152/AJPGI.00420.2002
Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells.
R. Sippel (2003)
10.1016/J.JSS.2005.01.003
A mouse model of carcinoid syndrome and heart disease.
Sandeepa Musunuru (2005)
Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells.
R. Irby (2002)
10.1128/MCB.17.9.5598
Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1.
D. Woods (1997)
10.1158/1535-7163.MCT-04-0334
ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells
J. V. Van Gompel (2005)
10.1210/JC.2005-0540
Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.
E. Nakakura (2005)
10.1016/S1072-7515(98)00225-7
Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients.
D. Elias (1998)
10.1016/S0039-6060(03)00418-5
The role of human achaete-scute homolog-1 in medullary thyroid cancer cells.
R. Sippel (2003)
10.1016/S0039-6060(96)80284-4
Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1.
H. Chen (1996)
10.1016/S1072-7515(98)00099-4
Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?
H. Chen (1998)
10.1038/sj.onc.1201270
Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1
Elizabeth Bosch (1997)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar